Findings from a study conducted by Dr. Chris Gaj, Vice President at Research Partnership, have been published in Clinical Genitourinary Cancer.
The study, led by Johnson and Johnson, explored using real world evidence collected by patient records from physicians to examine the impact of genetic mutations on response to therapy in urothelial carcinoma.
Discover more about how we help to shape the future of oncology treatments here.
Inizio Medical today proudly launches a new campaign that calls on the MedComms industry to do more to promote greater diversity in the sector.
Read moreInizio has once again shown that it’s a dominant force in the North American healthcare marketing landscape.
Read moreInizio Engage announces the launch of its new global experiential agency, Emota, merging Ashfield Event Experiences (AEE) and WRG.
Read more